FNY Investment Advisers’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,000
Closed -$8K 1446
2025
Q3
$8K Buy
+3,000
New +$10.7K ﹤0.01% 847
2025
Q2
Sell
-4,000
Closed -$14K 1180
2025
Q1
$14K Buy
+4,000
New +$14.6K 0.01% 446
2024
Q1
Sell
-30,208
Closed -$87K 838
2023
Q4
$87K Buy
+30,208
New +$47.6K 0.1% 145
2023
Q3
Sell
-33,389
Closed -$71K 749
2023
Q2
$71K Buy
+33,389
New +$81K 0.09% 137
2022
Q3
Sell
-54,747
Closed -$175K 833
2022
Q2
$175K Buy
+54,747
New +$159K 0.13% 111
2020
Q1
Sell
-73,862
Closed -$331K 791
2019
Q4
$331K Buy
+73,862
New +$459K 0.1% 149

Other funds holding STIM

FNY Investment Advisers's STIM Position: Q4 2025 in Review

FNY Investment Advisers sold out of Neuronetics (STIM) in Q4 2025, closing a stake of 3,000 shares — an estimated $8K sold.

FNY Investment Advisers first reported a position in STIM in Q4 2019 and held it in 6 quarters. The position peaked at $331K in Q4 2019. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

  • FNY Investment Advisers reported no remaining Neuronetics position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 3,000 Neuronetics shares in Q4 2025, an estimated $8K.
  • FNY Investment Advisers first reported a position in Neuronetics in Q4 2019 and held it in 6 quarters.
  • FNY Investment Advisers's Neuronetics position peaked at $331K in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.